Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03449849 · ClinicalTrials.gov registry record · NA
Effect of Kale Consumption on Human Xenobiotic Metabolizing Enzymes
A NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03449849 is a NA study that has completed, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 27 participants.
The verdict
NCT03449849, a NA study, has completed, sponsored by USDA Beltsville Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine how daily consumption of kale changes the activity of human xenobiotic metabolizing enzymes. Secondary objectives are to measure absorption and metabolism of kale phytonutrients, and to determine how kale consumption affects gene expression related to metabolism and lipid measures associated with cardiovascular health.
Interventions
- OTHER Base Diet
- OTHER Kale Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2018-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03449849
The ClinicalTrials.gov registry entry for NCT03449849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA Beltsville Human Nutrition Research Center, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Base Diet is the first listed.
NCT03449849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03449849 about?
NCT03449849 is a clinical study titled "Effect of Kale Consumption on Human Xenobiotic Metabolizing Enzymes". The primary objective of this study is to determine how daily consumption of kale changes the activity of human xenobiotic metabolizing enzymes. Secondary objectives are to measure absorption and metabolism of kale phytonutrients, and to determine how kale consumption affects gene expression related...
What is the current status of trial NCT03449849?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-04-18. Estimated completion is 2018-08-01.
What interventions are being tested in trial NCT03449849?
The interventions under investigation include: Base Diet (OTHER), Kale Treatment (OTHER).
Who is sponsoring clinical trial NCT03449849?
This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.